|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 505 KING AVENUE |
Address2 |
|
City | COLUMBUS |
State | OH |
Zip Code | 43201-2693 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 5585-12
|
||||||||
|
6. House ID# 302170000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Paul T. Doucette |
Date | 7/20/2018 10:45:16 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 5895; S. 2975; Energy and Water Development Appropriations Bill, 2019; Title III, Department of Energy, all provisions and issues relating to the Department of Energy, and its science, energy, and national security programs.
H.R. 5952, S. 3072; Commerce, Justice, Science and Related Agencies Appropriations Bill, 2019; NASA, Science, Planetary Science, Technology, provisions related to deep space missions; NOAA, Office of Oceanic and Atmospheric Research (OAR), Procurement, Acquisition and Construction, provisions related to research super computing; National Science Foundation, Research and Related Activities; FBI, provisions related to biodefense lab operations
H.R. 3219, H.R. 695, H.R. 6157, S. 3159; Defense Appropriations Bill, 2018/2019; Research, Development, Test, and Evaluation; issues related to the Joint Program Executive Office for Chemical and Biological Defense; retrofitable anti-icing technologies; non-standard commercial vehicles; O&M Budget Defense Health Agency, Biological Dosimetry Network for Radiological/Nuclear Events; Defense Health Program, Operational Risk Management of Deployment Exposures, Medical Technology Development, Biomarker Development
S.3109, Draft House Bill; Department of Homeland Security Appropriations Bill, 2019; Science and Technology Directorate, all issues related to laboratory facilities, and research, development, acquisition, and operations; all issues related to BioWatch program, issues related to chemical and biological readiness.
H.R.5961 S.2976; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; FDA Deeming Regulations issues
Draft House Bill, S. 3158; Departments of Labor, Health and Human Services and Related Agencies, 2019; Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Strategy for Combating Antibiotic Resistant Bacteria (CARB); Centers for Disease Control and Prevention,Issues related to Center for Disease Control's Opioid Research grants, National Center for Environmental Health, Agency for Toxic Substance and Disease Register, Division of Environmental Hazards and Health Effects, National Environmental and Public Health Tracking Network; CMS/Center for Program Integrity, Medicare Advantage, issues related to combating waste, fraud, and abuse; National Cancer Institute, Center for Cancer Research, issues related to computing and data analytics.
H.R. 5786 S 3024; MilCon-VA; VA - Veteran's Health Administration; Medical & Prosthetic Research; Million Veteran Program
Issues related to the Administration's Fiscal Year 2019 budget request for the Department of Energy and its science, energy, and national security programs.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Toler |
|
|
|
Paul |
Doucette |
|
|
|
Micah |
Edmond |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
H.R. 5515, S. 2987; House and Senate National Defense Authorization Act for Fiscal Year 2019; Research, Development, Test, and Evaluation; issues related to the Joint Program Executive Office for Chemical and Biological Defense; retrofitable anti-icing technologies; Other Authorization, Non Destructive Counterfeit Parts Detection Tools; Counter UAS options and capablities; Department of Energy National Security Authorizations; Minor Construction Threshold for Plant Projects; and Other Authorizations
Issues related to NNSA Defense Nuclear Nonproliferation programs.
Chemical and Biological Defense programs; next generation bio detector systems; retrofit-able anti-icing technologies for UAVs; Counter UAS options and capabilities; Non-standard Commercial Vehicles
CDMRP-SCIRP; Congressional Directed Medical Research Program -Spinal Cord Injury Research Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Micah |
Edmond |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ENG
16. Specific lobbying issues
H.R. 589, S. 2503; Department of Energy Research and Innovation Act; All titles and sections.
Issues related to Department of Energy technology transfer and commercialization policies.
Issues related to smart grid and electricity cybersecurity
Issues related to nuclear infrastructure and advanced reactor technologies
Issues related to NRC and licensing
Issues related to biological and environmental research
Issues related to DOE's renewable energy, energy efficiency, nuclear energy R&D programs.
Issues related to the Administration's Fiscal Year 2019 budget request for the Department of Energy and its science, energy, and national security programs.
Issues related to DOE manufacturing programs.
Issues related to DOE facilities infrastructure and operations
Issues related to Department of Energy environmental management program
Issues related to laboratory management.
Issues related to nominees for DOE positions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Toler |
|
|
|
Paul |
Doucette |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
H.R. 6227; National Quantum Initiative Act; Title I, National Quantum Initiative; Title IV Department of Energy Research and National Quantum Information Science Research Centers
Issues related to the Department of Energy Office of Science funding, programs, facilities, and initiatives.
Issues related to nuclear physics research and facilities.
Issues related to Department of Energy technology transfer and commercialization policies.
Issues related to federal funding for basic scientific research.
Issues related to Department of Energy supercomputing and quantum initiatives.
Issues related to fusion energy research and international collaborations.
Issues related to national laboratory facilities and infrastructure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mary |
Toler |
|
|
|
Paul |
Doucette |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HOM
16. Specific lobbying issues
Issues related to the Department of Homeland Security's Biowatch program
Issues related to DHS Science and Technology Directorate chem-bio defense mission and laboratory operations
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Doucette |
|
|
|
Micah |
Edmond |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues related to Center for Disease Control's Opioid Research grants;
Issues related to NIH's Marijuana Testing
Issues related to Deeming Regulations for E-Cigarettes and Premium Tobacco
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Micah |
Edmond |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |